Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1980 Feb;39(2):442–448.

Cellular hypersensitivity to tuberculin in BCG-revaccinated persons studied by skin reactivity, leucocyte migration inhibition and lymphocyte proliferation.

H Repo, A A Kostiala, T U Kosunen
PMCID: PMC1538059  PMID: 6993072

Abstract

Some persons seem to lose long-standing peripheral hypersensitivity to tuberculin earlier than others. This was seen in a group of five healthy student nurses who had been BCG-vaccinated as children and were found, in routine skin testing, to be negative to 100 TU of tuberculin purified protein derivative (PPD). They were revaccinated, which resulted in conversion to 10 TU skin test positivity. In agreement with this, their buffy coat cells achieved reactivity to 100 microgram/ml of PPD in a leucocyte migration inhibitory factor (LIF) assay. However, the LIF response, being maximal at 4 weeks, faded away earlier than skin reactivity. Peripheral blood lymphocyte proliferation was studied with several PPD concentrations, 10 microgram/ml always inducing the maximum 3H-thymidine uptake. This was still high at 6 months after vaccination, when the skin reactions tended to be smaller than earlier. The reason why the various parameters of cellular hypersensitivity followed different courses is not known, but it may involve different subpopulations of lymphocytes, activity of suppressor cells or influence by serum factors such as mycobacterial antigen-antibody complexes.

Full text

PDF
442

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blomgren H. Role of B cells in the expression of the PPD response of human lymphocytes in vitro. Scand J Immunol. 1975 Sep;4(5-6):499–510. doi: 10.1111/j.1365-3083.1975.tb02655.x. [DOI] [PubMed] [Google Scholar]
  2. Bona C., Chedid L. Stimulation of lymphocytes by purified protein derivative: suppression by cells from human vaccinated with Bacille Calmette-Guérin. J Infect Dis. 1976 Apr;133(4):465–468. doi: 10.1093/infdis/133.4.465. [DOI] [PubMed] [Google Scholar]
  3. Boyum A. Separation of blood leucocytes, granulocytes and lymphocytes. Tissue Antigens. 1974;4(4):269–274. [PubMed] [Google Scholar]
  4. Chess L., MacDermott R. P., Schlossman S. F. Immunologic functions of isolated human lymphocyte subpopulations. II. Antigen triggering of T and B cells in vitro. J Immunol. 1974 Oct;113(4):1122–1127. [PubMed] [Google Scholar]
  5. Clausen J. E. Tuberculin-induced migration inhibition of human peripheral leucocytes in agarose medium. Acta Allergol. 1971 Feb;26(1):56–80. doi: 10.1111/j.1398-9995.1971.tb01399.x. [DOI] [PubMed] [Google Scholar]
  6. Doroszczak N., Yoshida T., Cohen S. Subpopulations of lymphocytes to produce various lymphokines. I. Function of subpopulations separated by velocity sedimentation. J Immunol. 1977 Nov;119(5):1617–1620. [PubMed] [Google Scholar]
  7. Fleer A., van der Hart M., Blok-Schut B. J., Schellekens P. T. Correlation of PPD and BCG-induced leukocyte migration inhibition, delayed cutaneous hypersensitivity, lymphocyte transformation in vitro and humoral antibodies to PPD in man. Eur J Immunol. 1976 Mar;6(3):163–167. doi: 10.1002/eji.1830060305. [DOI] [PubMed] [Google Scholar]
  8. Hoffman P. M., Hanes D. M., Horsmanheimo M., Fudenberg H. H. Leukocyte migration in guinea pigs. II. Partial characterization of a leukocyte migration inhibitory factor distinct from macrophage migration inhibitory factor. Cell Immunol. 1977 Apr;30(1):92–99. doi: 10.1016/0008-8749(77)90050-8. [DOI] [PubMed] [Google Scholar]
  9. Hoffman P. M., Spitler L. E., Hsu M. Leukocyte-migration inhibition in guinea pigs. I. Correlation with skin test reactivity and macrophage-migration inhibition. Cell Immunol. 1976 Feb;21(2):358–363. doi: 10.1016/0008-8749(76)90064-2. [DOI] [PubMed] [Google Scholar]
  10. Jensen B., Kurpisz M., Rubin B. Antigen specific lymphocyte activity in vitro by peripheral blood leucocytes from Mantoux positive and negative human beings. I. Comparison of quantitative and qualitative differences in the PPD-specific lymphoproliferative response of lymphocytes from the two kinds of donors. Clin Exp Immunol. 1977 Feb;27(2):303–312. [PMC free article] [PubMed] [Google Scholar]
  11. Kostiala A. A., Lefford M. J., McGregor D. D. Immunological memory in tuberculosis. 2. Mediators of protective immunity, delayed hypersensitivity and macrophage migration inhibition in central lymph. Cell Immunol. 1978 Nov;41(1):9–19. doi: 10.1016/s0008-8749(78)80024-0. [DOI] [PubMed] [Google Scholar]
  12. Littman B. H., David J. R., Rocklin R. E. Migration inhibitory factor (MIF) and proliferative responses by human lymphocyte subpopulations separated by sheep erythrocyte rosette formation. Cell Immunol. 1976 Jun 15;24(2):241–249. doi: 10.1016/0008-8749(76)90209-4. [DOI] [PubMed] [Google Scholar]
  13. Miller S. D., Jones H. E. Correlation of lymphocyte transformation with tuberculin skin-test sensitivity. Am Rev Respir Dis. 1973 Apr;107(4):530–538. doi: 10.1164/arrd.1973.107.4.530. [DOI] [PubMed] [Google Scholar]
  14. Nilsson B. S. The response of lymphocytes from tuberculin-positive or negative humans to various doses of PPD-tuberculin in vitro. Cell Immunol. 1972 Mar;3(3):493–500. doi: 10.1016/0008-8749(72)90254-7. [DOI] [PubMed] [Google Scholar]
  15. Repo H. Leukocyte migration agarose test for the assessment of human neutrophil chemotaxis. I. Effects of environmental factors on neutrophil migration under agarose. Scand J Immunol. 1977;6(3):203–209. doi: 10.1111/j.1365-3083.1977.tb00385.x. [DOI] [PubMed] [Google Scholar]
  16. Rocklin R. E., Rosenthal A. S. Evidence that human leukocyte inhibitory factor (LIF) is an esterase. J Immunol. 1977 Jul;119(1):249–252. [PubMed] [Google Scholar]
  17. Räsänen L. Cellular co-operation in the production of human leucocyte inhibitory factor by lymphocyte subpopulations stimulated with antigens and allogeneic cells. Immunology. 1979 Aug;37(4):715–721. [PMC free article] [PubMed] [Google Scholar]
  18. Selroos O., Pasternack A., Virolainen M. Skin test sensitivity and antigen-induced lymphocyte transformation in uraemia. Clin Exp Immunol. 1973 Jul;14(3):365–370. [PMC free article] [PubMed] [Google Scholar]
  19. Senyk G., Hadley W. K. In vitro correlates of delayed hypersensitivity in man: ambiguity of polymorphonuclear neutrophils as indicator cells in leukocyte migration test. Infect Immun. 1973 Sep;8(3):370–380. doi: 10.1128/iai.8.3.370-380.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Thomas J. W., Clements D., Grzybowski S. In vitro lymphocyte responses and skin test reactivity following BCG vaccination. Clin Exp Immunol. 1971 Nov;9(5):611–623. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES